Publication Ethics

To uphold the highest standards of integrity, transparency, and accountability in scholarly publishing, our journal has established the following editorial policies:

 

Authors have the right to appeal editorial decisions or raise concerns about the peer review or editorial process such as long delays in handling papers. Appeals must be submitted in writing and provide detailed reasoning supported by evidence. Appeals will be reviewed by the Editor-in-Chief or the Editor who handled the paper. All appeals are considered carefully and impartially, and final decisions will be communicated in a timely manner.
Complaints involving publication ethics will be taken seriously. The Editor-in-Chief will assess such complaints and address them in accordance with the guidelines established by the Committee on Publication Ethics (COPE).

 

We follow the authorship guidelines outlined by the International Committee of Medical Journal Editors (ICMJE), which define the roles and responsibilities of authors and contributors. To be listed as an author, individuals must have made substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; All authors must actively participate in drafting the work or reviewing it critically for important intellectual content and approving the final version. Therefore, authors must take collective responsibility for the entire content of the manuscript. At the time of submission, each co-author is required to provide their full name, institutional email address (institutional emails are preferred), affiliation, country, full postal address and telephone number. The corresponding author must also include their ORCID iD. We encourage all co-authors to provide their unique identifiers, such as ORCID iDs, Scopus Author IDs, Web of Science Researcher IDs, Loop Profiles, or links to personal web pages.

 

All participants in the publication process—including authors, peer reviewers, editors, and editorial staff—are required to disclose any financial or non-financial relationships and activities that could be perceived as potential conflicts of interest. Each article will be published with a Conflict of Interest Statement, detailing any declared relationships and activities, as well as the role of funders (if applicable) in the design, conduct, or reporting of the work. We follow the recommendations of the International Committee of Medical Journal Editors (ICMJE), along with the ethical principles promoted by COPE and WAME. 

If errors are identified in published articles, the journal will issue corrections when necessary.

-  The Academic Medical Journal will publish a correction notice as soon as possible, detailing the changes made and citing the original publication. The correction will appear on a numbered electronic or print page and will be included in the electronic or print Table of Contents to ensure proper indexing.

-  A new version of the article will be posted, clearly indicating the specific changes made and the date(s) on which those changes occurred.

-  The journal will archive all previous versions of the article. This archive will either be directly accessible to readers or available upon request.

-  All previous electronic versions of the article will prominently state that a more recent version is available.

-  Citations should refer to the most recent version of the article to ensure accuracy and consistency in the scientific record.

 

In cases of serious scientific or ethical issues, such as data fabrication or plagiarism, the journal may retract the article following COPE (Committee on Publication Ethics) guidelines. However, if the error is due to an honest mistake (such as a miscalculation or misclassification) and the corrected version remains scientifically valid after editorial and peer review, the journal may consider retraction with republication (also called "replacement").

The corrected article will be published with a clear explanation of the changes, and the extent of those changes may be detailed in supplementary material or an appendix to ensure full transparency.

 

All submissions are screened for plagiarism using appropriate detection software. The journal defines plagiarism as the unacknowledged use of another's work, ideas, or words, whether published or unpublished. Manuscripts with evidence of plagiarism will be rejected or retracted, and appropriate action may be taken in accordance with COPE guidelines.

 

• names, initials, addresses, or hospital numbers
• dates (birth, admission, operation)
• rare diagnoses combined with other specific details
• facial or distinctive images
• unique clinical presentations that allow recognition

• Authors must disclose any use of generative AI tools (such as large language models, including chatbots) in the preparation of their manuscript, except for straightforward language correction, editing, or formatting.
• Authors are responsible for verifying the validity and accuracy of any outputs generated by automated tools used in their research and manuscript preparation.
• Automated tools cannot be listed as authors.
• Generative AI cannot be cited as a source.

• Peer reviewers and editors must not use generative AI to create their assessments, due to risks including breaches of confidentiality, superficial or non-specific feedback, bias, hidden prompts, and false information (such as fake references).
• Editing or rewriting using AI may be acceptable if fully disclosed.
• Any routine use of automated tools by the journal or publisher must be disclosed and tested for reliability.
• All use of automated tools must be overseen by humans (human in the loop).  Editors are responsible for verifying automated detection of integrity issues, including text similarity, figure manipulation or duplication, undeclared AI use, or automated peer reviewer suggestions.